Simplification of Low Level Internal Dosimetry
NCT03580161 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12
Last updated 2023-06-27
Summary
This is a pilot study with the primary aim being to identify the minimum number of scans and measurements necessary to determine accurately the absorbed radiation doses delivered from internal sources of radiation administered for diagnostic nuclear medicine procedures.
Conditions
- Exposure to Medical Diagnostic Radiation
Interventions
- OTHER
-
18-F FDG PET/CT dosimetry scans and measurements
Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans
- OTHER
-
Ga-68 PSMA PET/CT dosimetry scans and measurements
Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans
- OTHER
-
68-Ga Dotatate PET/CT dosimetry scans and measurements
Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans
- OTHER
-
99mTc Pertechnetate Thyroid dosimetry scans and measurements
Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans
- OTHER
-
99mTc DMSA(III) Renal dosimetry scans and measurements
Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans
- OTHER
-
99mTc MAG3 Renal dosimetry scans and measurements
Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans
- OTHER
-
99mTc MDP/HDP Bone dosimetry scans and measurements
Participants will have additional scans and retention measurements for dosimetry alongside their routine diagnostic scans
Sponsors & Collaborators
-
Royal Marsden NHS Foundation Trust
lead OTHER
Principal Investigators
-
Glenn Flux · Royal Marsden NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-06-30
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Ultralow Dose PET Imaging of 18F-FDG Uptake
NCT06956391 ·Status: RECRUITING ·Phase: PHASE2
-
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73
NCT06995976 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Two Bed SPECT/CT Versus Planar Bone Scintigraphy in Detection of Osseous Metastases in Patients With Genitourinary Malignancies
NCT05597215 ·Status: UNKNOWN
-
Imaging 61CuATSM Uptake in Atherosclerotic Plaque Using PET-CT
NCT01000181 ·Status: SUSPENDED
-
MPDL3280A-imaging-IST-UMCG
NCT02453984 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Radiation Dosimetry, Metabolism, Safety, Tolerability and Positron Emission Tomography/Computed Tomography (PET/CT) Imaging With BAY 85-8050 in Healthy Volunteers and Patients
NCT00961831 ·Status: COMPLETED ·Phase: PHASE1
-
Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification
NCT03603925 ·Status: COMPLETED
-
An International Study on the Use of PET/CT in Radiotherapy Planning in Low and Middle Income Countries
NCT02247713 ·Status: UNKNOWN
-
Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies
NCT04332419 ·Status: COMPLETED ·Phase: NA
-
Semi-automated Segmentation Methods of SSTR PET for Dosimetry Prediction
NCT05537675 ·Status: COMPLETED
-
In-Room PET in Proton Radiation Therapy
NCT01228448 ·Status: COMPLETED ·Phase: NA
-
FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer
NCT01432002 ·Status: UNKNOWN
-
Clinical Translation of a Novel Albumin-Binding PET Radiotracer 68Ga-NEB
NCT02496013 ·Status: UNKNOWN ·Phase: PHASE1
-
Comparative Analysis of SUV Measurements Using Different Correction Methods in Oncological PET/CT Imaging.
NCT07306975 ·Status: NOT_YET_RECRUITING
-
68Ga-PSMA PET Imaging of Upper Metastatic Gastric Cancers to Determine Eligibility to Endoradiotherapy
NCT05214820 ·Status: RECRUITING ·Phase: PHASE2
-
Construction and Clinical Translation of ACE Targeted Nuclear Medicine Imaging Probe
NCT06203119 ·Status: RECRUITING
-
PET-CT in Lymphoma Among the Eldery
NCT07259941 ·Status: NOT_YET_RECRUITING
-
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG
NCT05160480 ·Status: ENROLLING_BY_INVITATION
-
68Ga-PSMA PET/CT for Ra223 Assessment
NCT04951817 ·Status: RECRUITING ·Phase: NA
-
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors
NCT05490264 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Study on B7-H3 Targeted Affibody Radioligand Probes for PET Imaging of Solid Tumors
NCT06454955 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Assessment of Investigational Positron Emission Tomography and Post-Processing Procedures Performed as Add-ons to Standard of Care Imaging
NCT03490812 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment Evaluation
NCT00894101 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Pilot Project: Fast Whole-body Spect Scanning to Improve the Detection of Bone Metastases in Patients With Diagnosed Cancer
NCT00824213 ·Status: COMPLETED